The average one-year price target for Aprea Therapeutics (NasdaqCM:APRE) has been revised to $5.44 / share. This is a decrease of 20.00% from the prior estimate of $6.80 dated February 1, 2026. The ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Shares of Aprea Therapeutics, Inc. (APRE) have been struggling lately and have lost 11.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...
Explore Aprea Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APRE. FDA clearance for Aprea Therapeutics' APR-1051 IND application, a promising ...
Aprea Therapeutics, Inc. (APRE) stock price is 0.91 and Aprea Therapeutics, Inc. (APRE) 10-day simple moving average is 0.83. Aprea Therapeutics, Inc. (APRE) stock price is 0.91 and Aprea Therapeutics ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results